Drug profile · INN
cosyntropin
COSYNTROPIN
cosyntropin (COSYNTROPIN) is a melanocortin receptor 2 agonist. Associated with Amphastar France Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.
Drug details — cosyntropin
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
cosyntropin (COSYNTROPIN) is a melanocortin receptor 2 agonist. Associated with Amphastar France Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Melanocortin receptor 2 agonist
Primary target: Adrenocorticotropic hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is cosyntropin?
cosyntropin (COSYNTROPIN) is a melanocortin receptor 2 agonist. Associated with Amphastar France Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cosyntropin?
COSYNTROPIN is a marketed brand name for cosyntropin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cosyntropin?
cosyntropin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.